Abstract
The aim of this study was to investigate the effects of the active oyster peptide extract (AOPs) microcapsules formed with microemulsion gelling method, in order to prolong the bioactivity provided by this ingredient. Bioassay and release tests were done on the microencapsulated formulations. The microcapsules obtained were characterised in terms of particle size and morphology, DSC, FTIR, encapsulation efficiency (EE) and release studies. The particle size and EE of AOPs microcapsules with an loading capacity of about 18.29 % (wt%) ranged from 0.77 to 5.33 µm, and 71.46 to 75.37 %, respectively. The sustained release was observed in simulated intestinal fluid. The release behaviour of microspheres conformed best to Ritger–Peppas model (R2 = 0.98). For inflammatory cytokine, AOPs microcapsules was shown to effectively attenuated the IL-1β and TNF-α, increased the levels of ACP and lysozyme.
Similar content being viewed by others
References
P.A. Harnedy, R.J. Fitzgerald, J. Funct. Foods 4, 6–24 (2012)
S.K. Kim, L. Wijesekara, J. Funct. Foods 2, 1–9 (2010)
R. Hartmann, H. Meisel, Curr. Opin. Biotechnol. 18, 163–169 (2007)
J.A. Tincu, S.W. Taylor, Antimicrob. Agents Chemother. 48, 3645–3654 (2004)
G.K. Grimble, Nestle Nutr. Workshop Ser. Clin. Perform. Programme 3, 63–88 (2000)
Y.K. Wang et al., Mar. Drugs 8, 255–268 (2010)
D. Güzey, D. J. McClements, Food Biophys. 1(1), 30–40 (2006).
F. Weinbreck et al., J. Microencapsul. 21(6), 667–679 (2004)
Sajad Ahmad Wani, Pradyuman, Kumar, J. Food Meas. Charact. 10(3), 690–700 (2016)
L. Zhang et al., J. Food Process. Preserv. 39(4), 404–412 (2015)
L.W. Chan et al., J. Microencapsul. 14, 545–555 (1997)
C.M. Silva et al., Int. J. Pharm. 311, 1–10 (2006)
C. Nils et al, Anal. Biochem. 411, 116–121 (2011)
A. K. Anal et al, Int. J. Pharm. 312, 166–173 (2006)
P.L. Ritger, N.A. Peppas, J. Control Release 5, 23–36 (1987)
D. Shugar, Biochem Biophys Acta 8, 302–309 (1952).
C. Gabay, I. Kushner, N. Engl. J. Med. 340, 448–454 (1999)
C.A. Dinarello, Annu. Rev. Immunol. 27, 519–550 (2009)
T. Zor, Z. Selinger, Anal. Biochem. 236, 302–308 (1996)
Y.Z. Chen et al., Chin. Chem. Lett. 26, 909–913 (2015)
S.S. Gao et al., Int. J. Pharm. 427, 410–416 (2012)
N. Dan, J. Food Eng. 175, 136–144 (2016)
D. J. McClements, E. A. Decker, Designing Functional Foods (2009), pp. 502–546
J. M. Lakkis, Encapsulation and Controlled Release Technologies in Food Systems. ISBN: 13 9780813828558$4 Blackwell Publishing Professional. 113–149 (2007)
A.H. Ghassemi et al, Control Release 138, 57–63 (2009).
A.H. Ghassemi et al, Pharm Res. 27, 2008–17 (2010)
M. Hornof et al., J. Control Release 89, 419–428 (2003)
A. Matalanis et al, Food Hydrocoll. 25(8), 1865–1880 (2011)
I. D. Alvim, C. R. F. Grosso, Ciênc Tecnol. Aliment. 4, 1069–1076 (2010).
P.R. Hari et al., J. Appl. Pol. Sci. 59(11), 1795–1801 (1996)
V.J. Stella, R.A. Rajeswski, Pharm. Res. 14, 556–567 (1997)
T. Pariot et al., Int. J. Pharm. 232, 175–181 (2002)
A.H. Ghassemi et al, Pharmaceut. Res. 29(1):110–120 (2011).
R. Verma. S. Garg. J. Pharmaceut. Biomed. 35, 449–458 (2004).
Z.T. Yuan et al., Int. J. Pharm. 446, 191–198 (2013)
A. Polk et al., J. Pharm. Sci. 83, 178–185 (1994)
J. R. Jones, L. L. Hench, Bioactive 3D Scaffolds in Regenerative Medicine. ISBN: 9780849334467. 545–572 (2005).
E.M. Attwood et al., Tuber. Lung Dis. 77, 341–347 (1996)
Acknowledgments
This work was supported by Shandong University Foundation (Weihai) (1070513423004).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
All authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Zhang, X., Zhang, L., Xu, M. et al. Synthesis of microencapsulated oyster peptides and its effect on inflammatory cytokines and enzyme levels in mice. Food Measure 11, 610–620 (2017). https://doi.org/10.1007/s11694-016-9429-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11694-016-9429-6